Drug Eluting Balloons Market

A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.

Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.

Drug Eluting Balloons Market contains market size and forecasts of Drug Eluting Balloons (DEB) in global, including the following market information:

Global Drug Eluting Balloons (DEB) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Drug Eluting Balloons (DEB) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Drug Eluting Balloons (DEB) companies in 2021 (%)

The global Drug Eluting Balloons (DEB) market was valued at 600.9 million in 2021 and is projected to reach US$ 1373.6 million by 2028, at a CAGR of 12.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Peripheral DEBs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drug Eluting Balloons (DEB) include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance and Biotronic. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Drug Eluting Balloons (DEB) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug Eluting Balloons (DEB) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug Eluting Balloons (DEB) Market Segment Percentages, by Type, 2021 (%)

Peripheral DEBs

Coronary DEBs

Global Drug Eluting Balloons (DEB) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug Eluting Balloons (DEB) Market Segment Percentages, by Application, 2021 (%)

Catheterization Laboratory

Hospital

Others

Global Drug Eluting Balloons (DEB) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Drug Eluting Balloons (DEB) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug Eluting Balloons (DEB) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Drug Eluting Balloons (DEB) revenues share in global market, 2021 (%)

Key companies Drug Eluting Balloons (DEB) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Drug Eluting Balloons (DEB) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

B. Braun

Medtronic

Boston Scientific

BD

Yinyi

Philips

Eurocor

Aachen Resonance

Biotronic